147 related articles for article (PubMed ID: 1464160)
41. Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 cells.
Van Brocklyn J; Bremer EG; Yates AJ
J Neurochem; 1993 Jul; 61(1):371-4. PubMed ID: 8515285
[TBL] [Abstract][Full Text] [Related]
42. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
Kasayama S; Saito H; Kouhara H; Sumitani S; Sato B
J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
[TBL] [Abstract][Full Text] [Related]
43. Ca2+-mobilizing actions of platelet-derived growth factor differ from those of bombesin and vasopressin in Swiss 3T3 mouse cells.
Lopez-Rivas A; Mendoza SA; Nånberg E; Sinnett-Smith J; Rozengurt E
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5768-72. PubMed ID: 3039507
[TBL] [Abstract][Full Text] [Related]
44. Suramin blocks growth-stimulatory effects of platelet-derived growth factor on malignant fibrous histiocytomas in vitro.
Abdiu A; Larsson SE; Wasteson A; Walz TM
Cancer Lett; 1999 Nov; 146(2):189-94. PubMed ID: 10656625
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of glycosylphosphatidylinositol (GPI) phospholipase D by suramin-like compounds.
Brunner G; Zalkow L; Burgess E; Rifkin DB; Wilson EL; Gruszecka-Kowalik E; Powis G
Anticancer Res; 1996; 16(5A):2513-6. PubMed ID: 8917344
[TBL] [Abstract][Full Text] [Related]
46. Increased intracellular Ca2+ signaling caused by the antitumor agent helenalin and its analogues.
Powis G; Gallegos A; Abraham RT; Ashendel CL; Zalkow LH; Grindey GB; Bonjouklian R
Cancer Chemother Pharmacol; 1994; 34(4):344-50. PubMed ID: 8033301
[TBL] [Abstract][Full Text] [Related]
47. Suramin enters and accumulates in low pH intracellular compartments of v-sis-transformed NIH 3T3 cells.
Huang SS; Koh HA; Huang JS
FEBS Lett; 1997 Oct; 416(3):297-301. PubMed ID: 9373173
[TBL] [Abstract][Full Text] [Related]
48. Effects of suramin on human platelet aggregation and Ca2+ mobilization induced by thrombin and other agonists.
Siafaka-Kapadai A; Svetlov S; Hanahan DJ; Javors MA
Life Sci; 1998; 63(20):1769-77. PubMed ID: 9820121
[TBL] [Abstract][Full Text] [Related]
49. Lycopene binding compromised PDGF-AA/-AB signaling and migration in smooth muscle cells and fibroblasts: prediction of the possible lycopene binding site within PDGF.
Chen CP; Hung CF; Lee SC; Lo HM; Wu PH; Wu WB
Naunyn Schmiedebergs Arch Pharmacol; 2010 May; 381(5):401-14. PubMed ID: 20237770
[TBL] [Abstract][Full Text] [Related]
50. Suramin is a potent inhibitor of calcemic hormone- and growth factor-induced bone resorption in vitro.
Farsoudi KH; Pietschmann P; Cross HS; Peterlik M
J Pharmacol Exp Ther; 1993 Feb; 264(2):579-83. PubMed ID: 8382276
[TBL] [Abstract][Full Text] [Related]
51. Specificity of inositol trisphosphate-induced calcium release from permeabilized Swiss-mouse 3T3 cells.
Irvine RF; Brown KD; Berridge MJ
Biochem J; 1984 Aug; 222(1):269-72. PubMed ID: 6332622
[TBL] [Abstract][Full Text] [Related]
52. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ
J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539
[TBL] [Abstract][Full Text] [Related]
53. Platelet derived growth factor-evoked Ca2+ wave and matrix gene expression through phospholipase C in human pulmonary fibroblast.
Mukherjee S; Duan F; Kolb MR; Janssen LJ
Int J Biochem Cell Biol; 2013 Jul; 45(7):1516-24. PubMed ID: 23618877
[TBL] [Abstract][Full Text] [Related]
54. Transforming growth factor-beta 1 inhibitory effect of platelet-derived growth factor-induced signal transduction on human bone marrow fibroblasts: possible involvement of protein phosphatases.
Fontenay M; Bryckaert M; Tobelem G
J Cell Physiol; 1992 Sep; 152(3):507-19. PubMed ID: 1324246
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
Weber H; Taylor DS; Molloy CJ
J Clin Invest; 1994 Feb; 93(2):788-98. PubMed ID: 7509348
[TBL] [Abstract][Full Text] [Related]
56. Involvement of Ca(2+)-calmodulin in platelet-derived growth factor-, fibroblast growth factor-, and insulin-induced ornithine decarboxylase in NIH-3T3 cells.
Katori T; Yasuda H; Fukuda H; Kimura S
Metabolism; 1994 Jan; 43(1):4-10. PubMed ID: 8289674
[TBL] [Abstract][Full Text] [Related]
57. Regulation of PDGF-beta receptor-operated Ca2+ channels by phospholipase C-gamma 1 in glomerular mesangial cells.
Ma H; Matsunaga H; Li B; Marrero MB; Ling BN
Am J Physiol; 1996 Nov; 271(5 Pt 2):F994-1003. PubMed ID: 8945993
[TBL] [Abstract][Full Text] [Related]
58. Biological function of PDGF-induced PI-3 kinase activity: its role in alpha PDGF receptor-mediated mitogenic signaling.
Yu JC; Gutkind JS; Mahadevan D; Li W; Meyers KA; Pierce JH; Heidaran MA
J Cell Biol; 1994 Oct; 127(2):479-87. PubMed ID: 7929590
[TBL] [Abstract][Full Text] [Related]
59. Involvement of Ca2+ in platelet-derived growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts.
Tsuda T; Kaibuchi K; West B; Takai Y
FEBS Lett; 1985 Jul; 187(1):43-6. PubMed ID: 3926536
[TBL] [Abstract][Full Text] [Related]
60. The effect of schedule, protein binding and growth factors on the activity of suramin.
Lopez Lopez R; Peters GJ; van Loenen AC; Pizao PE; van Rijswijk RE; Wagstaff J; Pinedo HM
Int J Cancer; 1992 Jul; 51(6):921-6. PubMed ID: 1639540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
